Harrow, Inc. shares fall 1.82% intraday after announcing participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference.

miércoles, 6 de agosto de 2025, 12:36 pm ET1 min de lectura
HROW--
Harrow, Inc. declined 1.82% in intraday trading, with the company announcing its participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference on August 13, 2025. The event will feature a fireside chat and a panel discussion led by Harrow’s CEO and CFO, which could potentially influence investor sentiment and stock performance.

Harrow, Inc. shares fall 1.82% intraday after announcing participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios